Compugen reported $93.54M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
aTyr Pharma USD 97.99M 97.9M Sep/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 93.54M 3.99M Jun/2025
RedHill Biopharma USD 33.3B 20.4B Jun/2025